Literature DB >> 24264576

GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptor.

Madelaine Cho-Clark1, Darwin O Larco, Nina N Semsarzadeh, Florencia Vasta, Shaila K Mani, T John Wu.   

Abstract

The decapeptide GnRH is known for its central role in the regulation of the hypothalamo-pituitary-gonadal axis. In addition, it is also known to have local effects within peripheral tissues. The zinc metalloendopeptidase, EC 3.4.24.15 (EP24.15), can cleave GnRH at the Tyr(5)-Gly(6) bond to form the pentapeptide, GnRH-(1-5). The central and peripheral effect of GnRH-(1-5) is different from its parent peptide, GnRH. In the current study, we examined the effect of GnRH-(1-5) on epidermal growth factor receptor (EGFR) phosphorylation and cellular migration. Using the Ishikawa cell line as a model of endometrial cancer, we demonstrate that GnRH-(1-5) stimulates epidermal growth factor release, increases the phosphorylation of EGFR (P < .05) at three tyrosine sites (992, 1045, 1068), and promotes cellular migration. In addition, we also demonstrate that these actions of GnRH-(1-5) are mediated by the orphan G protein-coupled receptor 101 (GPR101). Down-regulation of GPR101 expression blocked the GnRH-(1-5)-mediated release of epidermal growth factor and the subsequent phosphorylation of EGFR and cellular migration. These results suggest that GPR101 is a critical requirement for GnRH-(1-5) transactivation of EGFR in Ishikawa cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24264576      PMCID: PMC5426651          DOI: 10.1210/me.2013-1203

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  83 in total

1.  Regulation of type II luteinizing hormone-releasing hormone (LHRH-II) gene expression by the processed peptide of LHRH-I, LHRH-(1-5) in endometrial cells.

Authors:  Emily L Baldwin; Iga N Wegorzewska; Michael Flora; T John Wu
Journal:  Exp Biol Med (Maywood)       Date:  2007-01

2.  Gonadotropin-releasing hormone induces miR-132 and miR-212 to regulate cellular morphology and migration in immortalized LbetaT2 pituitary gonadotrope cells.

Authors:  Joseph Godoy; Marin Nishimura; Nicholas J G Webster
Journal:  Mol Endocrinol       Date:  2011-03-03

3.  Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence.

Authors:  H Matsuo; Y Baba; R M Nair; A Arimura; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1971-06-18       Impact factor: 3.575

4.  Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.

Authors:  Lydia W T Cheung; Peter C K Leung; Alice S T Wong
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

5.  Stimulation of luteinizing hormone-releasing hormone (LHRH) gene expression in GT1-7 cells by its metabolite, LHRH-(1-5).

Authors:  T J Wu; Shaila K Mani; Marc J Glucksman; James L Roberts
Journal:  Endocrinology       Date:  2004-10-14       Impact factor: 4.736

Review 6.  Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.

Authors:  Wai-Kin So; Jung-Chien Cheng; Song-Ling Poon; Peter C K Leung
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

7.  Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion.

Authors:  Song Ling Poon; Gareth T Hammond; Peter C K Leung
Journal:  Mol Endocrinol       Date:  2009-07-16

8.  High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.

Authors:  G Emons; O Ortmann; M Becker; G Irmer; B Springer; R Laun; F Hölzel; K D Schulz; A V Schally
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

9.  The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells.

Authors:  Gerard W Dougherty; Cynthia Jose; Mario Gimona; Mary Lou Cutler
Journal:  Eur J Cell Biol       Date:  2008-04-23       Impact factor: 4.492

10.  Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.

Authors:  Hsien-Ming Wu; Jung-Chien Cheng; Hsin-Shih Wang; Hong-Yuan Huang; Colin D MacCalman; Peter C K Leung
Journal:  Cancer Res       Date:  2009-04-14       Impact factor: 12.701

View more
  15 in total

Review 1.  Peripheral and Central Mechanisms Involved in the Hormonal Control of Male and Female Reproduction.

Authors:  L M Rudolph; G E Bentley; R S Calandra; A H Paredes; M Tesone; T J Wu; P E Micevych
Journal:  J Neuroendocrinol       Date:  2016-07       Impact factor: 3.627

2.  Screening for GPR101 defects in pediatric pituitary corticotropinomas.

Authors:  Giampaolo Trivellin; Ricardo R Correa; Maria Batsis; Fabio R Faucz; Prashant Chittiboina; Ivana Bjelobaba; Darwin O Larco; Martha Quezado; Adrian F Daly; Stanko S Stojilkovic; T John Wu; Albert Beckers; Maya Lodish; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2016-06-01       Impact factor: 5.678

3.  Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.

Authors:  Giampaolo Trivellin; Adrian F Daly; Fabio R Faucz; Bo Yuan; Liliya Rostomyan; Darwin O Larco; Marie Helene Schernthaner-Reiter; Eva Szarek; Letícia F Leal; Jean-Hubert Caberg; Emilie Castermans; Chiara Villa; Aggeliki Dimopoulos; Prashant Chittiboina; Paraskevi Xekouki; Nalini Shah; Daniel Metzger; Philippe A Lysy; Emanuele Ferrante; Natalia Strebkova; Nadia Mazerkina; Maria Chiara Zatelli; Maya Lodish; Anelia Horvath; Rodrigo Bertollo de Alexandre; Allison D Manning; Isaac Levy; Margaret F Keil; Maria de la Luz Sierra; Leonor Palmeira; Wouter Coppieters; Michel Georges; Luciana A Naves; Mauricette Jamar; Vincent Bours; T John Wu; Catherine S Choong; Jerome Bertherat; Philippe Chanson; Peter Kamenický; William E Farrell; Anne Barlier; Martha Quezado; Ivana Bjelobaba; Stanko S Stojilkovic; Jurgen Wess; Stefano Costanzi; Pengfei Liu; James R Lupski; Albert Beckers; Constantine A Stratakis
Journal:  N Engl J Med       Date:  2014-12-03       Impact factor: 91.245

4.  Autoshortloop feedback regulation of pulsatile gonadotropin-releasing hormone (GnRH) secretion by its metabolite, GnRH-(1-5).

Authors:  Darwin O Larco; Melissa Williams; Lauren Schmidt; Nick Sabel; Jason Lange; Michael J Woller; T J Wu
Journal:  Endocrine       Date:  2014-12-17       Impact factor: 3.633

5.  GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency.

Authors:  F Castinetti; A F Daly; C A Stratakis; J-H Caberg; E Castermans; G Trivellin; L Rostomyan; A Saveanu; N Jullien; R Reynaud; A Barlier; V Bours; T Brue; A Beckers
Journal:  Horm Metab Res       Date:  2016-01-21       Impact factor: 2.936

Review 6.  Neuropeptide and steroid hormone mediators of neuroendocrine regulation.

Authors:  A L Heck; C C Crestani; A Fernández-Guasti; D O Larco; A Mayerhofer; C E Roselli
Journal:  J Neuroendocrinol       Date:  2018-08-07       Impact factor: 3.627

7.  GnRH-(1-5) Inhibits TGF-β Signaling to Regulate the Migration of Immortalized Gonadotropin-Releasing Hormone Neurons.

Authors:  Darwin O Larco; Bradly M Bauman; Madelaine Cho-Clark; Shaila K Mani; T John Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

8.  Regulation of Gonadotropin-Releasing Hormone-(1-5) Signaling Genes by Estradiol Is Age Dependent.

Authors:  Bradly M Bauman; Weiling Yin; Andrea C Gore; T John Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-27       Impact factor: 5.555

9.  Characterization of the G protein-coupled receptor family SREB across fish evolution.

Authors:  Timothy S Breton; William G B Sampson; Benjamin Clifford; Anyssa M Phaneuf; Ilze Smidt; Tamera True; Andrew R Wilcox; Taylor Lipscomb; Casey Murray; Matthew A DiMaggio
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 10.  Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research.

Authors:  Zhixiang Wang
Journal:  Int J Mol Sci       Date:  2016-01-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.